Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |